These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4076290)

  • 1. Plasma testosterone and breast cancer.
    Hill P; Garbaczewski L; Kasumi F
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1265-6. PubMed ID: 4076290
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone levels in the plasma of normal women and patients with benign breast disease or with breast cancer.
    Wang DY; Hayward JL; Bulbrook RD
    Eur J Cancer (1965); 1966 Dec; 2(4):373-6. PubMed ID: 5980828
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma testosterone in advanced breast cancer.
    Horn H; Gordan GS
    Oncology; 1974; 30(2):147-51. PubMed ID: 4449632
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood levels of testosterone and dihydrotestosterone in breast cancer].
    Vitola GIa; Zeĭkate GA
    Vopr Onkol; 1976; 22(8):26-30. PubMed ID: 997415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on apparent free cortisol and testosterone in plasma from patients with breast tumours.
    Jones MK; Dyer GI; Ramsay ID; Collins WP
    Postgrad Med J; 1981 Feb; 57(664):89-94. PubMed ID: 7267513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating hormone concentrations in women with breast cancer.
    McFadyen IJ; Forrest AP; Prescott RJ; Golder MP; Groom GV; Fahmy DR; Griffiths K
    Lancet; 1976 May; 1(7969):1100-2. PubMed ID: 57508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum oestradiol-17 beta, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer.
    Ribeiro GG; Phillips HV; Skinner LG
    Br J Cancer; 1980 Mar; 41(3):474-7. PubMed ID: 6770883
    [No Abstract]   [Full Text] [Related]  

  • 9. A study on plasma sex hormone levels in patients with breast cancer.
    Chen F; Wang SS; Dai QT; Xing LY; Lu WY; Yang WX; Wang ZG; Yao FY
    Chin Med J (Engl); 1985 Jul; 98(7):507-10. PubMed ID: 3932015
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum levels of prolactin, estradiol, testosterone and sex hormone-binding globulin in women with breast cancer treated with cytostatics and anti-estrogens].
    Grodecka-Gazdecka S; Baron J
    Ginekol Pol; 1986 Dec; 57(12):778-83. PubMed ID: 3570023
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women.
    Lønning PE; Dowsett M; Jacobs S; Schem B; Hardy J; Powles TJ
    J Steroid Biochem; 1989; 34(1-6):551-3. PubMed ID: 2626050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.
    Secreto G; Recchione C; Cavalleri A; Miraglia M; Dati V
    Br J Cancer; 1983 Feb; 47(2):269-75. PubMed ID: 6824571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated estradiol and testosterone levels and risk for breast cancer.
    Yu H; Diamandis EP; Hoffman B
    Ann Intern Med; 1999 Nov; 131(9):715. PubMed ID: 10577342
    [No Abstract]   [Full Text] [Related]  

  • 14. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
    Zeleniuch-Jacquotte A; Bruning PF; Bonfrer JM; Koenig KL; Shore RE; Kim MY; Pasternack BS; Toniolo P
    Am J Epidemiol; 1997 Jun; 145(11):1030-8. PubMed ID: 9169912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma testosterone and prognosis of postmenopausal breast cancer patients.
    Micheli A; Meneghini E; Secreto G; Berrino F; Venturelli E; Cavalleri A; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Veronesi U; Formelli F
    J Clin Oncol; 2007 Jul; 25(19):2685-90. PubMed ID: 17548841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone and biological characteristics of breast cancers in postmenopausal women.
    Secreto G; Venturelli E; Meneghini E; Greco M; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F; Cavalleri A; Micheli A
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2942-8. PubMed ID: 19843675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma estrogens and androgens in male breast cancer.
    Calabresi E; De Giuli G; Becciolini A; Giannotti P; Lombardi G; Serio M
    J Steroid Biochem; 1976 Aug; 7():605-9. PubMed ID: 134178
    [No Abstract]   [Full Text] [Related]  

  • 19. Change in serum oestradiol and testosterone concentrations after mastectomy for breast cancer with high aromatase activity.
    Tsunoda Y; Shimizu Y; Tsunoda A; Kamiya K; Sawada T; Kusano M; Ohta H
    Eur J Surg; 2001 Mar; 167(3):234-6. PubMed ID: 11316415
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.
    Campagnoli C; Pasanisi P; Abbà C; Ambroggio S; Biglia N; Brucato T; Colombero R; Danese S; Donadio M; Venturelli E; Zito G; Berrino F
    Clin Breast Cancer; 2012 Jun; 12(3):175-82. PubMed ID: 22607767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.